Abstract

Anxiety disorders are prevalent across the United States and result in a large personal and societal burden. Currently, numerous therapeutic and pharmaceutical treatment options exist. However, drugs to classical receptor targets have shown limited efficacy and often come with unpleasant side effects, highlighting the need to identify novel targets involved in the etiology and treatment of anxiety disorders. GPR83, a recently deorphanized receptor activated by the abundant neuropeptide PEN, has also been identified as a glucocorticoid regulated receptor (and named GIR) suggesting that this receptor may be involved in stress-responses that underlie anxiety. Consistent with this, GPR83 null mice have been found to be resistant to stress-induced anxiety. However, studies examining the role of GPR83 within specific brain regions or potential sex differences have been lacking. In this study, we investigate anxiety-related behaviors in male and female mice with global knockout and following local GPR83 knockdown in female mice. We find that a global knockdown of GPR83 has minimal impact on anxiety-like behaviors in female mice and a decrease in anxiety-related behaviors in male mice. In contrast, a local GPR83 knockdown in the basolateral amygdala leads to more anxiety-related behaviors in female mice. Local GPR83 knockdown in the central amygdala or nucleus accumbens (NAc) showed no significant effect on anxiety-related behaviors. Finally, dexamethasone administration leads to a significant decrease in receptor expression in the amygdala and NAc of female mice. Together, our studies uncover a significant, but divergent role for GPR83 in different brain regions in the regulation of anxiety-related behaviors, which is furthermore dependent on sex.

Highlights

  • Anxiety disorders manifest in a variety of symptoms, but often involve excessive and/or persistent worry and fear that is considered maladaptive and intensifies over time

  • We find that a small population of GPR83 positive cells in the nucleus accumbens (NAc) express parvalbumin suggesting the presence of this receptor in some GABAergic neurons (Figures 3J–M)

  • We find that dexamethasone administration has no effect on GPR83 expression in the amygdala of male mice and a decrease in expression in female mice

Read more

Summary

Introduction

Anxiety disorders manifest in a variety of symptoms, but often involve excessive and/or persistent worry and fear that is considered maladaptive and intensifies over time. These disorders occur in approximately 20% of the population, and represent a significant societal and economic burden. Despite decades of continued research into the treatment of anxiety by targeting these major neurotransmitter systems, little progress has been made in the development of more efficacious treatments This has led to a shift in research focus to other lesser known neurotransmitter and peptide systems with the intent of identifying the generation of anxiolytics. One underutilized source of novel therapeutics is the pool of orphan G protein-coupled receptors (GPCRs) whose endogenous ligands are beginning to be explored

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call